Synlab AG (FRA:SYAB) Debt-to-Asset : 0.33 (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Synlab AG Debt-to-Asset?

Synlab AG's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was €158 Mil. Synlab AG's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was €1,388 Mil. Synlab AG's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Mar. 2024 was €4,707 Mil. Synlab AG's debt to asset for the quarter that ended in Mar. 2024 was 0.33.

Synlab AG Debt-to-Asset Historical Data

The historical data trend for Synlab AG's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Synlab AG Debt-to-Asset Chart

Synlab AG Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Debt-to-Asset

0.59

0.37

0.39

0.34

Synlab AG Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Debt-to-Asset	Get a 7-Day Free Trial											0.38	0.39	0.35	0.34	0.33

Competitive Comparison of Synlab AG's Debt-to-Asset

For the Diagnostics & Research subindustry, Synlab AG's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Synlab AG's Debt-to-Asset Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Synlab AG's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Synlab AG's Debt-to-Asset falls into.

Synlab AG Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Synlab AG's Debt-to-Asset for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(157.269	+	1402.768)	/	4663.266
	=	0.33

Synlab AG's Debt-to-Asset for the quarter that ended in Mar. 2024 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(157.729	+	1387.795)	/	4707.237
	=	0.33

Synlab AG (FRA:SYAB) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Synlab AG Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Synlab AG's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Synlab AG (FRA:SYAB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Synlab AG (FRA:SYAB) » Definitions » Debt-to-Asset

Comparable Companies

Traded in Other Exchanges

SYAB:Germany

Address

Moosacher Strasse 88, Augsburg, BY, DEU, 80809

Website

https://www.synlab.de

Synlab AG is a medical diagnostics services provider in Europe. It offers a range of medical diagnostic services for practising doctors, clinics, and patients. Its geographical segments include France; Germany; South and North and East. The company derives a majority of revenue from the North and East.

Synlab AG (FRA:SYAB) Headlines

No Headlines